Sk Biopharmaceuticalsco Stock Net Income
326030 Stock | 88,600 1,200 1.34% |
Sk BiopharmaceuticalsCo fundamentals help investors to digest information that contributes to Sk Biopharmaceutica's financial success or failures. It also enables traders to predict the movement of 326030 Stock. The fundamental analysis module provides a way to measure Sk Biopharmaceutica's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sk Biopharmaceutica stock.
326030 |
Sk BiopharmaceuticalsCo Company Net Income Analysis
Sk Biopharmaceutica's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Sk Biopharmaceutica Net Income | 64.85 B |
Most of Sk Biopharmaceutica's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sk BiopharmaceuticalsCo is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition |
Based on the recorded statements, Sk BiopharmaceuticalsCo reported net income of 64.85 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Biotechnology industry. The net income for all Republic of Korea stocks is significantly lower than that of the firm.
326030 Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sk Biopharmaceutica's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sk Biopharmaceutica could also be used in its relative valuation, which is a method of valuing Sk Biopharmaceutica by comparing valuation metrics of similar companies.Sk Biopharmaceutica is currently under evaluation in net income category among related companies.
326030 Fundamentals
Return On Equity | -0.12 | |||
Return On Asset | 0.0475 | |||
Profit Margin | (0.12) % | |||
Operating Margin | 0.11 % | |||
Current Valuation | 5.87 T | |||
Shares Outstanding | 78.31 M | |||
Shares Owned By Insiders | 64.28 % | |||
Shares Owned By Institutions | 5.26 % | |||
Price To Book | 15.89 X | |||
Price To Sales | 13.94 X | |||
Revenue | 418.64 B | |||
Gross Profit | 396.31 B | |||
EBITDA | 83.87 B | |||
Net Income | 64.85 B | |||
Cash Flow From Operations | (92.87 B) | |||
Earnings Per Share | (117.74) X | |||
Target Price | 96154.0 | |||
Number Of Employees | 10 | |||
Beta | 1.11 | |||
Market Capitalization | 5.32 T | |||
Total Asset | 643.65 B | |||
Net Asset | 643.65 B |
About Sk Biopharmaceutica Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sk BiopharmaceuticalsCo's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sk Biopharmaceutica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sk BiopharmaceuticalsCo based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Sk Biopharmaceutica in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Sk Biopharmaceutica's short interest history, or implied volatility extrapolated from Sk Biopharmaceutica options trading.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Sk BiopharmaceuticalsCo. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Sk BiopharmaceuticalsCo information on this page should be used as a complementary analysis to other Sk Biopharmaceutica's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for 326030 Stock analysis
When running Sk Biopharmaceutica's price analysis, check to measure Sk Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sk Biopharmaceutica is operating at the current time. Most of Sk Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of Sk Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sk Biopharmaceutica's price. Additionally, you may evaluate how the addition of Sk Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |